Verification of immunce system before intravesical instillation of BCG in the urinary bladder in cases of transitional cell carcinoma – a conditio sine qua non?

被引：0

作者：

W. Werner

H. Wunderlich

U. Markert

J. Schubert

机构：

[1] Urologische Klinik der Friedrich-Schiller-Universität Jena,

[2] Institut für Klinische Immunologie,undefined

[3] Friedrich-Schiller-Universität Jena,undefined

来源：

Der Urologe | 1999年 / 38卷

关键词：

Key words Bladder cancer • Immunotest • Immunotherapy • BCG; Schlüsselwörter Harnblasenkarzinom • Immuntest • Immuntherapie • BCG;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The intravesical instillation of BCG (Bacillus Calmette-Guérin) in cases of relapsed superficial bladder cancer is an acknowledged kind of prophylaxis. It is uncertainly up to now whether a verification of the immune systems competence is necessary. The recommendations in this problem are very different. In conclusion to the recent literature we think that a verification of the immune system before BCG installation in the urinary bladder has not a prognostic value. Additionally, the legal obligingness of this immunotest is doubtful.

引用

页码：51 / 55

页数：4